FDA approves vaccine
Johnson&Johnson has received approval for emergency use of its vaccine in the US, with the advantages of single-dose administration and standard storage requirements.
Johnson&Johnson receiv...
Vaccine trial and delivery
Johnson & Johnson is preparing to present the results of the final trials of its COVID-19 vaccine in the next week or two, according to Anthony Fauci, chief medical officer for infectious ...
Delay in supply
The US company has notified Italy of a 29% temporary reduction in the supply of the drug, with the authorities believing it would have a negative impact on the vaccination campaign. Pfizer explained that the delays were due to a prod...
Supply disruptions
Vaccine supplies to Europe are at risk as there is a shortage of vaccines already approved there, the head of BioNTech said.
German bioengineering company BioNTech is working ...
Ending the year with growth
The US stock market ends 2020 on an upswing despite the COVID-19 pandemic.
The Standard Poor's 500 Index jumped 66% from this year's low in March, the early days of the pandemic. Leading the gains were shares of Tesla (N...
Formula for success
In November, the drug showed an average of 70% protection against coronavirus. According to AstraZeneca's chief executive, subsequent trials will demonstrate that it can compete with vaccines from Pfizer and Moderna.
Anglo-Swedi...
US trades
The US stock market ended Friday's trading in negative territory after posting record highs a day earlier. However, major indicators ended the week on the plus side, with the S&P 500 up 1.3% and the Dow Jones up 0.4%. The Nasdaq was up...
Recovery of the United States economy
The Fed can keep rates zero for another three to four years while the US economy recovers and inflation reaches 2% or more.
Charles Evans, President of the Chicago Federal Reserve Bank,...
The fight against covid
The British company's vaccine had an average efficiency of 70%, but one of the methods of administration showed a 90% efficiency.
AZD 1222 vaccine against coronavirus infection COVID-19, which is being developed in the UK, s...
- 1
- 2
NEW YORK NEWS
News from GlobalNY.biz is the freshest and most relevant information about high-profile events in the region. The task of the resource's news feed is to convey to readers with maximum accuracy and objectivity information about important events in business, politics, economy, healthcare, culture and other spheres of life in New York.
GlobalNY.biz news is a coverage of economic processes taking place in New York, the latest news of public life, incidents and an overview of political events. New York news is information about the activities of small and medium-sized businesses, the work of housing and communal services and utilities, the implementation of significant projects.
The site's journalists describe not only the life of the region, but also talk about the current state of the US economy. Everything you need to know about innovations in the field of industry and agriculture, economy and power is collected in the "News" section at GlobalNY.biz.
New York news quickly informs the reader, shows the real picture and opens up hot topics. Communication with government structures and business enables us to provide our readers with reliable, information-rich material. The main page of the portal contains the key news of New York!
Alena Potapova
Development Director
